Loading data
IPMNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 23.61 m USD | 1.1 m USD | 962.03 k USD | 10.99 m USD | 13.27 m USD |
| Cost of revenue | 11.27 m USD | 262.89 k USD | 284.89 k USD | 2.82 m USD | 2.72 m USD |
| Research and development expense | — | 215.54 k USD | 210.23 k USD | 5.93 m USD | 5.39 m USD |
| Operating profit | -4.72 m USD | -5.12 m USD | -3.7 m USD | -3.66 m USD | 519.49 k USD |
| Profit before tax | -4.28 m USD | -4.41 m USD | -2.71 m USD | -3.58 m USD | 1.33 m USD |
| Income tax expense | -2.33 m USD | -137.59 k USD | -27.95 k USD | -171.67 k USD | 9.95 k USD |
| Net income (reported basis) | -1.96 m USD | -8.43 m USD | -1.07 m USD | -3.41 m USD | 1.32 m USD |
| Net income attributable to common shareholders | -1.96 m USD | -8.43 m USD | -1.07 m USD | -3.41 m USD | — |
| Basic earnings per share | -0.15 USD/share | -0.91 USD/share | -0.12 USD/share | -0.35 USD/share | 0.17 USD/share |
| Diluted earnings per share | -0.15 USD/share | -0.91 USD/share | -0.12 USD/share | -0.35 USD/share | 0.17 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.